Activating mutations in the epidermal growth factor receptor gene in non-small cell lung cancer fixed tissue: Analysis and one center experience
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F12%3A00060613" target="_blank" >RIV/00216224:14110/12:00060613 - isvavai.cz</a>
Result on the web
<a href="http://dx.doi.org/10.1016/j.lungcan.2012.05.080" target="_blank" >http://dx.doi.org/10.1016/j.lungcan.2012.05.080</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.lungcan.2012.05.080" target="_blank" >10.1016/j.lungcan.2012.05.080</a>
Alternative languages
Result language
angličtina
Original language name
Activating mutations in the epidermal growth factor receptor gene in non-small cell lung cancer fixed tissue: Analysis and one center experience
Original language description
Targeted treatment of patients with non small cell lung cancer (NSCLC) with tyrosine kinase inhibitors (TKI) of epidermal growth factor receptor gene (EGFR) is conditioned by EGFR mutation status assessment. Tyrosine kinase domains of exons 18?21 of geneEGFR was analysed in non selected NSCLC patients.
Czech name
—
Czech description
—
Classification
Type
O - Miscellaneous
CEP classification
FD - Oncology and haematology
OECD FORD branch
—
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2012
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů